ClinicalTrials.gg
CompletedNCT07353593Updated Jan 20, 2026

Effect of Kinesio Tape Versus Systemic Dexamethasone on Postsurgical Sequels Following Extraction of Impacted Mandibular Third Molars

A Phase 1 interventional study of Kinesio Tape application and Intramuscular Injection of Dexamethasone in Impacted Mandibular Third Molar Extraction, sponsored by Ashraf elanzy. Completed at 1 site in Egypt. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-20.

Sponsored by Ashraf elanzy · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Oct 2023, registered Dec 2025).
Phase
Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

The surgical removal of lower wisdom teeth is a common procedure that can cause pain, facial swelling, and difficulty in opening the mouth after surgery. These symptoms are usually managed with medications such as dexamethasone, which helps reduce inflammation but may have unwanted side effects in some patients.

This study compares the use of dexamethasone with Kinesio Tape, a non-drug treatment applied to the skin, to evaluate their effectiveness in reducing pain, swelling, and limited mouth opening after wisdom tooth removal. The findings of this study may help determine whether Kinesio Tape can be a safe and effective alternative to medication for improving recovery after surgery.

Read the detailed description

The extraction of impacted mandibular third molars is one of the most common procedures performed in oral and maxillofacial surgery. Despite being a routine intervention, it is frequently associated with significant postoperative complications, including pain, edema, and trismus, all of which negatively impact patient recovery and quality of life. These sequelae result from the inflammatory response induced by surgical trauma, leading to increased vascular permeability, extracellular fluid accumulation, and the release of inflammatory mediators. Given these concerns, optimizing postoperative management strategies is critical to improving patient outcomes and enhancing recovery. Traditional pharmacological interventions, particularly dexamethasone, have been widely employed due to their potent anti-inflammatory effects. However, concerns regarding systemic side effects, contraindications, and long-term implications have led to increasing interest in non-pharmacological alternatives such as Kinesio Tape (KT).

The physiological response following third molar extraction is driven by a complex interplay of cellular and molecular mechanisms aimed at tissue healing and immune regulation. Surgical trauma triggers the activation of pro-inflammatory cytokines, including tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6, which contribute to increased vascular permeability, edema formation, and nociceptor sensitization. This inflammatory cascade ultimately results in pain, swelling, and limited mouth opening due to spasm and fibrosis of the masticatory muscles, particularly the masseter and pterygoid muscles. The peak of these complications typically occurs within 48 hours postoperatively and, if not adequately managed, may lead to prolonged recovery, reduced oral function, and impaired patient satisfaction.

Dexamethasone is a long-acting glucocorticoid that exerts its effects by inhibiting the transcription of pro-inflammatory genes, thereby reducing cytokine release, stabilizing cell membranes, and preventing fluid extravasation into surrounding tissues. Evidence has shown that a single preoperative dose of dexamethasone administered via submucosal or intramuscular injection can effectively reduce postoperative swelling, trismus, and pain intensity, making it a widely adopted intervention in oral surgery. Nevertheless, despite its efficacy, systemic corticosteroids are associated with potential risks, including immunosuppression, delayed wound healing, alterations in glucose metabolism, and adrenal suppression with prolonged use. These concerns have necessitated the exploration of alternative strategies capable of achieving comparable anti-inflammatory effects without systemic exposure.

Kinesio Tape has gained increasing attention in rehabilitation medicine and sports therapy, with growing interest in its role in postoperative recovery. Designed to lift the skin, decompress underlying tissues, and enhance lymphatic drainage, KT has been proposed as an effective method for reducing edema, improving blood circulation, and modulating neuromuscular function. Unlike corticosteroids, which act at the molecular level to suppress inflammation, KT exerts its effects mechanically by redistributing interstitial pressure, facilitating fluid dynamics, and promoting natural healing mechanisms.

Clinical investigations have assessed the efficacy of KT in reducing postoperative complications following third molar extraction. Application of KT has been associated with reductions in swelling, pain intensity, and trismus during the early postoperative period, suggesting a sustained benefit in controlling tissue inflammation. Moreover, KT does not induce systemic effects, making it an attractive option for patients with contraindications to corticosteroid therapy.

Comparative evaluations between dexamethasone and KT in managing postoperative sequelae suggest that while dexamethasone provides a more immediate reduction in inflammation, KT offers a gradual and sustained improvement in edema resolution. KT application has also been associated with improved patient-reported comfort, potentially due to its continuous therapeutic effect throughout the postoperative period, in contrast to the transient pharmacological action of corticosteroids.

Despite promising findings regarding KT as an alternative or adjunct to dexamethasone, gaps remain in understanding its optimal clinical application, efficacy across diverse patient populations, and potential synergistic effects when combined with pharmacological interventions. This study aims to address these gaps by conducting a comprehensive comparative analysis of Kinesio Tape versus dexamethasone in mitigating postoperative pain, swelling, and trismus following mandibular third molar extraction. Through this investigation, the study seeks to contribute meaningful insights into the development of multimodal, minimally invasive postoperative management strategies in oral surgery.

02

Conditions studied

  • Impacted Mandibular Third Molar Extraction

Browse trials for

Keywords

  • Kinesio Tape, Dexamethasone, Mandibular Third Molar, Oral Surgery, Postoperative Edema, Pain Management, Trismus, Non-Pharmacological Therapy
03

In context

Trismus

107 studies on the registry are indexed under Trismus; 19 are open to participants now.

This study's enrollment of 30 is below the median of 52 across 99 interventional studies indexed under Trismus.

Browse Trismus studies →

Lead sponsor

This is the only study on the registry with Ashraf elanzy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients (male and female) with age 20-40 years old.
  2. Co-operative patients.
  3. An impacted lower wisdom tooth diagnosed with a moderate to severe difficulty index according to Pell and Gregory or Pederson scale classification.104
  4. Medically Free from any systemic conditions.

Exclusion criteria

Exclusion criteria:

  1. Uncooperative patients.
  2. Smoker patients.
  3. Pregnant or lactating women.
  4. Women taking oral .
  5. Patient with systemic diseases.
  6. Patients misunderstanding the clinical procedures of the study.
  7. Individuals allergic or intolerant to Dexamethasone used in the study.
  8. Patients on oral anticoagulants.
  9. Uncontrolled diabetic patients.
  10. Individuals with periodontal disease or active infection at the site of impacted tooth.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Kinesio Tape

    Other: Kinesio Tape application

  • Active comparator
    Dexamethasone

    Drug: Intramuscular Injection of Dexamethasone

  • Active comparator
    Control

    Other: control

Interventions

  • OtherKinesio Tape application

    Kinesio Tape application after horizontal impacted mandibular third molar extraction

  • DrugIntramuscular Injection of Dexamethasone

    8 M.g Intramuscular Injection of Dexamethasone\*\* after horizontal impacted mandibular third molar extraction

  • Othercontrol

    left to heal without use of Dexamethasone nor Kinesio Tape after horizontal impacted mandibular third molar extraction

06

What researchers measure

Primary outcomes

  1. Facial swelling (edema) measured in millimeters at three facial points after mandibular third molar extraction

    Edema will be assessed using a flexible ruler at three standardized points: 1. Lateral corner of the eye to angle of the mandible 2. Tragus to corner of the mouth 3. Inferior point of the angle of the mandible to lateral point of the lip commissure Measurements will be performed immediately after extraction, at 3 days, and at 7 days postoperatively.

    Time frame: Immediately after extraction, Day 3, and Day 7 postoperatively

  2. Maximum interincisal distance (mm) to assess mouth opening after mandibular third molar extraction

    Mouth opening will be measured as the maximum interincisal distance using a caliper. Measurements will be taken immediately after extraction, at 3 days, and at 7 days postoperatively.

    Time frame: Immediately after extraction, Day 3, and Day 7 postoperatively

  3. Pain intensity score after mandibular third molar extraction measured using the Visual Analog Scale (VAS, 1-10)

    Pain intensity will be self-reported by each participant using the Visual Analog Scale (VAS) ranging from 1 (no pain) to 10 (worst pain imaginable). Pain will be assessed immediately post-extraction, at 3 days, and at 7 days postoperatively.

    Time frame: Immediately after extraction, Day 3, and Day 7 postoperatively

07

Study locations

1 site
  • Mansura Universtiy
    Al Mansurah, Mansura 14323, Egypt
08

References and documents

Individual participant data

Plan to share: No — The study will not share individual participant data (IPD) outside the primary research group due to the small sample size and to protect participant confidentiality.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07353593
Lead sponsor
Ashraf elanzy
Collaborators
Mansoura University
Responsible party
Ashraf elanzy (Principal Investigator, Department of Oral and Maxillofacial Surgery, Mansoura University) — Sponsor-investigator
First posted
Jan 20, 2026
Start date
Oct 1, 2023
Primary completion
Sep 30, 2024
Completion
Apr 30, 2025
Last update
Jan 20, 2026

Study contacts

Mohamed Abdelmonem Tawfik, Prof
principal investigator · Mansoura University
Fakhreldin Hassan Abdelrahman, PHD
principal investigator · Mansoura University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion